Delivery Order V797D30042-36C26022F0140

Award Date 2/7/22
Potential Completion Date 2/6/23
Potential Value $100K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Veterans Integrated Service Network 20 of the Department of Veterans Affairs to Grifols Therapeutics LLC, a for-profit limited liability company that manufactures and supplies pharmaceuticals. The contract is for the delivery of the drug Prolastin and has a ceiling value of $83,755.20. The contract is a Firm Fixed Price delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not have a...
This is a federal contract award for PROLASTIN, a pharmaceutical product, issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule 61-IB. The contract is a delivery order with a firm fixed price of $75,000.00 and a period of...
This is a Firm Fixed Price delivery order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC. The award is for the bulk supply of Prolastin, a pharmaceutical drug, for the period from February 1, 2016 to January 31, 2017, with a potential ceiling value of $320,438.40. The award does not utilize any set-aside designation. Grifols Therapeutics LLC is a...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $223,184.16, is for the provision of PROLASTIN C, a pharmaceutical product, to the VA under the Pharmaceuticals and Drugs GSA Schedule contract. The contract is a firm fixed-price delivery order with a period of performance ending on September 30, 2017. The contract was...
This is a delivery order issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The $278,987.52 firm fixed price award is for the provision of unspecified DRUG products under the Pharmaceuticals and Drugs GSA Schedule contract. The order has a period of performance ending on March 15, 2017 and does not utilize a small business set-aside....
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...
This is a delivery order contract awarded by the Department of Veterans Affairs to Grifols Therapeutics LLC for the supply of Prolastin, a pharmaceutical product. The contract has a ceiling value of $144,000.00 and a period of performance from October 1, 2015 to September 30, 2016. It is a firm fixed price contract issued under the Pharmaceuticals and Drugs GSA Schedule. The award does not utilize any small business set-asides. Grifols Therapeutics LLC is a for-profit manufacturer and supplier...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of PROLASTIN-C, a pharmaceutical product, with a ceiling value of $214,014.72 and a period of performance through September 30, 2016. The contract is issued under the Pharmaceuticals and Drugs GSA Schedule vehicle and does not utilize...
This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,612.48, was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and involves the procurement of various pharmaceutical products such as Prolastin, Prolastin-C, and immune globulin. The contract has an ultimate completion date of May 25, 2017 and does...

This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a regional network within the U.S. Department of Veterans Affairs (VA), to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C, a drug product, and has a ceiling value of $100,281.60. The contract was awarded on a Firm Fixed Price basis under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a period of performance running through February 6, 2023. This award was not designated as a small business set-aside.

Generated 9/18/24, 9:02 AM